Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Idexx Laboratories, Inc (NASDAQ: IDXX) closed the day trading at $415.98 up 0.35% from the previous closing price of $414.52. In other words, the price has increased by $0.35 from its previous closing price. On the day, 0.53 million shares were traded. IDXX stock price reached its highest trading level at $418.54 during the session, while it also had its lowest trading level at $412.315.
Ratios:
For a better understanding of IDXX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 110.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 42.98. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 1.36. In the meantime, Its Debt-to-Equity ratio is 0.62 whereas as Long-Term Debt/Eq ratio is at 0.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on July 25, 2024, initiated with a Buy rating and assigned the stock a target price of $580.
On January 30, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $525.
On December 07, 2023, Exane BNP Paribas started tracking the stock assigning a Outperform rating and target price of $602.Exane BNP Paribas initiated its Outperform rating on December 07, 2023, with a $602 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 06 ’24 when SZOSTAK M ANNE sold 500 shares for $469.37 per share. The transaction valued at 234,686 led to the insider holds 0 shares of the business.
M. Anne Szostak bought 500 shares of IDXX for $234,890 on Sep 06 ’24. On May 17 ’24, another insider, Claflin Bruce L., who serves as the Director of the company, sold 200 shares for $540.80 each. As a result, the insider received 108,160 and left with 161 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDXX now has a Market Capitalization of 34062399488 and an Enterprise Value of 34752024576. As of this moment, Idexx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 40.13, and their Forward P/E ratio for the next fiscal year is 34.70. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.68. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.86 while its Price-to-Book (P/B) ratio in mrq is 21.09. Its current Enterprise Value per Revenue stands at 9.039 whereas that against EBITDA is 26.744.
Stock Price History:
Over the past 52 weeks, IDXX has reached a high of $583.39, while it has fallen to a 52-week low of $404.74. The 50-Day Moving Average of the stock is -12.62%, while the 200-Day Moving Average is calculated to be -17.19%.
Shares Statistics:
Over the past 3-months, IDXX traded about 515.89K shares per day on average, while over the past 10 days, IDXX traded about 854000 shares per day. A total of 83.03M shares are outstanding, with a floating share count of 81.01M. Insiders hold about 1.07% of the company’s shares, while institutions hold 93.92% stake in the company. Shares short for IDXX as of 1728950400 were 2288496 with a Short Ratio of 4.44, compared to 1726185600 on 2376337. Therefore, it implies a Short% of Shares Outstanding of 2288496 and a Short% of Float of 3.58.
